BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15995848)

  • 21. Effects of prolonged exposure to pancreatic glucagon on the function, antigenicity and survival of isolated human islets.
    Del Guerra S; Lupi R; Dotta F; Marselli L; Lencioni C; Santangelo C; Realacci M; Carmellini M; Mosca F; Navalesi R; Marchetti P
    Diabetes Metab Res Rev; 2000; 16(4):281-6. PubMed ID: 10934457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elastin peptides activate extracellular signal-regulated kinase 1/2 via a Ras-independent mechanism requiring both p110gamma/Raf-1 and protein kinase A/B-Raf signaling in human skin fibroblasts.
    Duca L; Lambert E; Debret R; Rothhut B; Blanchevoye C; Delacoux F; Hornebeck W; Martiny L; Debelle L
    Mol Pharmacol; 2005 Apr; 67(4):1315-24. PubMed ID: 15653554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term modulation of extracellular signal-regulated kinase 1/2 and stress-activated protein kinase/c-Jun NH2-terminal kinase in pancreatic islets by glucose and palmitate: possible involvement of ceramide.
    Nogueira TC; Graciano MF; Anhê GF; Curi R; Bordin S; Carpinelli AR
    Pancreas; 2009 Jul; 38(5):585-92. PubMed ID: 19295452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway.
    Hughes PJ; Brown G
    J Cell Biochem; 2006 Jun; 98(3):590-617. PubMed ID: 16440327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-Raf is required for ERK activation and tumor progression in a mouse model of pancreatic beta-cell carcinogenesis.
    Sobczak I; Galabova-Kovacs G; Sadzak I; Kren A; Christofori G; Baccarini M
    Oncogene; 2008 Aug; 27(35):4779-87. PubMed ID: 18490924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-terminal fragment of tetanus toxin heavy chain activates Akt and MEK/ERK signalling pathways in a Trk receptor-dependent manner in cultured cortical neurons.
    Gil C; Chaib-Oukadour I; Aguilera J
    Biochem J; 2003 Jul; 373(Pt 2):613-20. PubMed ID: 12710887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MEK-independent survival of B-RAFV600E melanoma cells selected for resistance to apoptosis induced by the RAF inhibitor PLX4720.
    Jiang CC; Lai F; Thorne RF; Yang F; Liu H; Hersey P; Zhang XD
    Clin Cancer Res; 2011 Feb; 17(4):721-30. PubMed ID: 21088259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3'-kinase-dependent pathway.
    Lin CY; Gurlo T; Haataja L; Hsueh WA; Butler PC
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6678-86. PubMed ID: 16204373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the Raf/MEK/ERK pathway with small-molecule inhibitors.
    McCubrey JA; Milella M; Tafuri A; Martelli AM; Lunghi P; Bonati A; Cervello M; Lee JT; Steelman LS
    Curr Opin Investig Drugs; 2008 Jun; 9(6):614-30. PubMed ID: 18516761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
    Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA
    Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leptin inhibits insulin secretion by activation of phosphodiesterase 3B.
    Zhao AZ; Bornfeldt KE; Beavo JA
    J Clin Invest; 1998 Sep; 102(5):869-73. PubMed ID: 9727054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follicle-Stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-lnduced kinase (Sgk): evidence for A kinase-independent signaling by FSH in granulosa cells.
    Gonzalez-Robayna IJ; Falender AE; Ochsner S; Firestone GL; Richards JS
    Mol Endocrinol; 2000 Aug; 14(8):1283-300. PubMed ID: 10935551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits beta-cell apoptosis in vitro.
    Bregenholt S; Møldrup A; Blume N; Karlsen AE; Nissen Friedrichsen B; Tornhave D; Knudsen LB; Petersen JS
    Biochem Biophys Res Commun; 2005 May; 330(2):577-84. PubMed ID: 15796922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats.
    Perfetti R; Zhou J; Doyle ME; Egan JM
    Endocrinology; 2000 Dec; 141(12):4600-5. PubMed ID: 11108273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucotoxicity and α cell dysfunction: involvement of the PI3K/Akt pathway in glucose-induced insulin resistance in rat islets and clonal αTC1-6 cells.
    Shen XX; Li HL; Pan L; Hong J; Xiao J; Hermansen K; Jeppesen PB; Li GW
    Endocr Res; 2012; 37(1):12-24. PubMed ID: 22007944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent developments in anti-cancer agents targeting the Ras/Raf/ MEK/ERK pathway.
    Wong KK
    Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):28-35. PubMed ID: 19149686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PACAP and GLP-1 protect islet beta-cells against Ca2+ toxicity induced by high K+.
    Yaekura K; Yanagida K; Yada T
    Ann N Y Acad Sci; 1998 Dec; 865():445-50. PubMed ID: 9928047
    [No Abstract]   [Full Text] [Related]  

  • 38. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways.
    Marte BM; Rodriguez-Viciana P; Wennström S; Warne PH; Downward J
    Curr Biol; 1997 Jan; 7(1):63-70. PubMed ID: 8999998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sorafenib paradoxically activates the RAS/RAF/ERK pathway in polyclonal human NK cells during expansion and thereby enhances effector functions in a dose- and time-dependent manner.
    Lohmeyer J; Nerreter T; Dotterweich J; Einsele H; Seggewiss-Bernhardt R
    Clin Exp Immunol; 2018 Jul; 193(1):64-72. PubMed ID: 29573266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential role of B-Raf in oligodendrocyte maturation and myelination during postnatal central nervous system development.
    Galabova-Kovacs G; Catalanotti F; Matzen D; Reyes GX; Zezula J; Herbst R; Silva A; Walter I; Baccarini M
    J Cell Biol; 2008 Mar; 180(5):947-55. PubMed ID: 18332218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.